Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 29;9(10):540.
doi: 10.3390/vetsci9100540.

Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma

Floryne O Buishand  1
Affiliations
Review

Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma

Floryne O Buishand. Vet Sci. .

Abstract

The most common pancreatic tumour in dogs is the insulinoma. Canine insulinomas are considered to be malignant in more than 95% of the cases because they almost always tend to metastasise. The diagnosis of an insulinoma requires the demonstration of the simultaneous occurrence of hypoglycaemia and blood insulin levels that are within or above the high end of the reference interval. The staging of canine insulinomas is preferably conducted by contrast-enhanced computed tomography. In general, surgical treatment is the most effective because of it results in long survival times, but many dogs also require medical treatment at some point. The prognosis of canine insulinomas is guarded as clinical hypoglycaemia almost always returns due to metastasis or tumour regrowth. This review aims to provide a summary and update the current recommendations in the veterinary literature for the diagnosis, treatment and prognostication of canine insulinomas.

Keywords: dog; insulinomas; pancreas; pancreatic neuroendocrine tumours.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Tobin R.L., Nelson R.W., Lucroy M.D., Wooldridge J.D., Feldman E.C. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990–1997) J. Am. Vet. Med. Assoc. 1999;215:226–230. - PubMed
    1. Mehlhaff C.J., Peterseon M.E., Patnaik A.K., Carillo J.M. Insulin-producing islet cell neoplasms: Surgical considerations and general management in 35 dogs. J. Am. Anim. Hosp. Assoc. 1985;21:607–612.
    1. Leifer C.E., Peterson M.E., Matus R.E. Insulin-secreting tumor: Diagnosis and medical and surgical management in 55 dogs. J. Am. Vet. Med. Assoc. 1986;188:60–64. - PubMed
    1. Caywood D.D., Klausner J.S., O’Leary T.P., Withrow S.J., Richardson R.C., Harvey H.J., Norris A.M., Henderson R.A., Johnston S.D. Pancreatic insulin-secreting neoplasms; clinical, diagnostic, and prognostic features in 73 dogs. J. Am. Anim. Hosp. Assoc. 1988;24:577–584.
    1. Fernandez N.J., Barton J., Spotswood T. Hypoglycemia in a dog. Can. Vet. J. 2009;50:423–426. - PMC - PubMed

LinkOut - more resources